This 5-year clinical scientist development award proposes the use of quantitative epidemiologic principles to relate post-mortem findings to neurologic conditions associated with aging. A spectrum of parkinsonian signs, including bradykinesia, rigidity, tremor, and gait imbalance are common in older persons without Parkinson's disease, and are associated with increased morbidity and mortality. The nigrostriatal system also shows a spectrum of change with age. Preliminary data suggest that nigral neurofibrillary pathology is more common than previously recognized and is related to parkinsonian signs in older persons with and without Alzheimer's disease. The proposed studies will relate nigral neurofibrillary pathology and biochemical nigrostriatal changes to quantitative measures of global and specific parkinsonian signs in older persons with and without Alzheimer's disease. We will test the hypotheses that neurofibrillary pathology, specifically within the pars compacta of the substantia nigra, rather than the ventral tegmental or retrorubral areas, accounts for parkinsonian signs in older persons with and without AD, and that the mechanism by which neurofibrillary pathology produces parkinsonian signs involves decreased gene expression of tyrosine hydroxylase and a reduction in striatal dopamine, but not neuronal loss. We will also determine the role of mitochondrial mutations in the pathogenesis of neurofibrillary pathology and parkinsonian signs. The proposed project will use brain tissue of 80 older persons, without Parkinson's disease, in The Religious Order Study, a longitudinal study of over 650 catholic clergy who have agreed to annual examinations and brain donation after death. The proposed study will provide the Candidate in the opportunity to work with senior colleagues and allow the development of a unique research area that integrates the clinical neurology and neuropathology training. Through the course of these studies and analyses, through didactic sessions with her sponsors and consultants, and related course work, the candidate will develop the skills necessary to become an independent investigator.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AG000849-03
Application #
6509362
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Finkelstein, Judith A
Project Start
2000-04-01
Project End
2005-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
3
Fiscal Year
2002
Total Cost
$120,420
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Cade, Brian E; Gottlieb, Daniel J; Lauderdale, Diane S et al. (2016) Common variants in DRD2 are associated with sleep duration: the CARe consortium. Hum Mol Genet 25:167-79
Lim, Andrew S P; Yu, Lei; Kowgier, Matthew et al. (2013) Modification of the relationship of the apolipoprotein E ?4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 70:1544-51
Bennett, David A; Schneider, Julie A; Arvanitakis, Zoe et al. (2012) Overview and findings from the religious orders study. Curr Alzheimer Res 9:628-45
Desai Bradaric, Brinda; Patel, Aditiben; Schneider, Julie A et al. (2012) Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm (Vienna) 119:59-71
Wang, Paul C; Blumenthal, Robert P; Zhao, Yuliang et al. (2009) Building scientific progress without borders: nanobiology and nanomedicine in China and the U.S. Cancer Res 69:5294-5
Desai, Brinda S; Schneider, Julie A; Li, Jia-Liang et al. (2009) Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna) 116:587-97
Schneider, Julie A; Aggarwal, Neelum T; Barnes, Lisa et al. (2009) The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis 18:691-701
Schneider, Julie A; Arvanitakis, Zoe; Leurgans, Sue E et al. (2009) The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 66:200-8
Arvanitakis, Z; Schneider, J A; Wilson, R S et al. (2008) Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 70:1795-802
Boyle, Patricia A; Buchman, Aron S; Wilson, Robert S et al. (2007) Physical activity is associated with incident disability in community-based older persons. J Am Geriatr Soc 55:195-201

Showing the most recent 10 out of 24 publications